These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1878605)

  • 21. The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study.
    Stemmer SM; Rizel S; Hardan I; Adamo A; Neumann A; Goffman J; Brenner HJ; Pfeffer MR
    J Clin Oncol; 2003 Jul; 21(14):2713-8. PubMed ID: 12860949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].
    Conti F; Carpano S; Sergi D; Di Lauro L; Amodio A; Vici P; Abbate MI; Ferranti FR; Viola G; Botti C; Foggi P; Sperduti I; Lopez M
    Clin Ter; 2007; 158(4):331-41. PubMed ID: 17953285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
    J Clin Oncol; 2004 Dec; 22(23):4691-9. PubMed ID: 15570071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodality therapy for locally advanced and limited stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy.
    Blumenschein GR; DiStefano A; Caderao J; Fristenberg B; Adams J; Schweichler LH; Drinkard L
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2633-7. PubMed ID: 10068266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI.
    Gruber G; Bonetti M; Nasi ML; Price KN; Castiglione-Gertsch M; Rudenstam CM; Holmberg SB; Lindtner J; Golouh R; Collins J; Crivellari D; Carbone A; Thürlimann B; Simoncini E; Fey MF; Gelber RD; Coates AS; Goldhirsch A;
    J Clin Oncol; 2005 Oct; 23(28):7089-97. PubMed ID: 16192592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
    Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
    Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
    Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Postmastectomy radiotherapy for early breast cancer].
    Wang S; Li Y; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):68-70. PubMed ID: 11977644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2].
    Renner H; van Kampen M
    Strahlenther Onkol; 1994 Aug; 170(8):441-52. PubMed ID: 8085210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumorectomy and radiation therapy in early breast cancer: a report on 392 patients.
    Dubois JB; Saumon-Reme M; Gary-Bobo J; Pourquier H; Pujol H
    Radiology; 1990 Jun; 175(3):867-71. PubMed ID: 2343138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB).
    Jacquillat C; Baillet F; Weil M; Auclerc G; Housset M; Auclerc M; Sellami M; Jindani A; Thill L; Soubrane C
    Cancer; 1988 May; 61(10):1977-82. PubMed ID: 3129176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary chemotherapy in breast cancer: correlation between tumor response and patient outcome.
    Ferrière JP; Assier I; Curé H; Charrier S; Kwiatkowski F; Achard JL; Dauplat J; Chollet P
    Am J Clin Oncol; 1998 Apr; 21(2):117-20. PubMed ID: 9537193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histological evaluation of the effects of intraarterial chemotherapy for advanced breast cancer: a long-term followup study with respect to the survival rate.
    Toda K; Hirata K; Sato T; Okazaki M; Asaishi K; Narimatsu E
    Surg Today; 1998; 28(5):509-16. PubMed ID: 9607903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The practical use of the determination of relative 32P accumulation in the tumor in breast cancer].
    Portnoĭ SM; Gabuniia RI; Godin VP; Letiagin VP
    Vopr Onkol; 1992; 38(8):986-92. PubMed ID: 1300811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional Therapy for Intact Primary Tumor in De Novo Stage IV Breast Cancer.
    Soran A; Aytac O; Ozbas S
    J Clin Oncol; 2022 Nov; 40(33):3897-3898. PubMed ID: 35820106
    [No Abstract]   [Full Text] [Related]  

  • 40. Do We Consider Locoregional Treatment of Primary Site in Patients With De Novo Stage IV Breast Cancer?: Numerous Data Are Accumulating!
    Altundag K
    Clin Breast Cancer; 2018 Jun; 18(3):e299. PubMed ID: 28784266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.